-
公开(公告)号:US20230024528A1
公开(公告)日:2023-01-26
申请号:US17782127
申请日:2020-12-04
Applicant: Alector LLC
Inventor: Tina SCHWABE , Ilaria TASSI , Arnon ROSENTHAL , Hua LONG , Santiago Viveros SALAZAR
Abstract: The present disclosure is generally directed to the use of anti-TREM2 antibodies in preventing, reducing risk, or treating disease in an individual in need thereof.
-
公开(公告)号:US20220411503A1
公开(公告)日:2022-12-29
申请号:US17831336
申请日:2022-06-02
Applicant: Alector LLC
Inventor: Kate MONROE , Helen LAM , Arnon ROSENTHAL , Seung-Joo LEE , Francesca AVOGADRI-CONNORS , William MONTEITH
IPC: C07K16/28 , A61K39/395 , A61K45/06
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a Siglec-7 protein, e.g., human Siglec-7 or a mammalian Siglec-7, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US20220281976A1
公开(公告)日:2022-09-08
申请号:US17752606
申请日:2022-05-24
Applicant: Alector LLC
Inventor: Arnon ROSENTHAL , Kate MONROE , Francesca AVOGADRI-CONNORS
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US20210317208A1
公开(公告)日:2021-10-14
申请号:US17272083
申请日:2019-08-30
Applicant: Alector LLC
Inventor: Patricia CULP , Helen LAM , Wei-Hsien HO , Leonard G. PRESTA , Arnon ROSENTHAL
IPC: C07K16/28
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a CD33 polypeptide, e.g., a mammalian CD33 or human CD33, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US20210246204A1
公开(公告)日:2021-08-12
申请号:US16972840
申请日:2019-06-07
Applicant: Alector LLC
Inventor: Patricia CULP , Seung-Joo LEE , Helen LAM , Wei-Hsien HO , Arnon ROSENTHAL
IPC: C07K16/28
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a Siglec-7 protein, e.g., human Siglec-7 or a mammalian Siglec-7, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US20210122817A1
公开(公告)日:2021-04-29
申请号:US16965675
申请日:2019-01-31
Applicant: Alector LLC
Inventor: Philip KONG , Herve RHINN , Tina SCHWABE , Angie YEE , Arnon ROSENTHAL
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a MS4A6A polypeptide, e.g., a mammalian MS4A6A or human MS4A6A, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US20210101978A1
公开(公告)日:2021-04-08
申请号:US17107302
申请日:2020-11-30
Applicant: Alector LLC
Inventor: Arnon ROSENTHAL
IPC: C07K16/28 , A61K39/395 , C07K14/725 , C07K14/705 , C07K16/24
Abstract: The present disclosure is related to compositions that include polynucleotides encoding chimeric receptors, methods of delivering polynucleotides encoding chimeric receptors to immune cells, and methods of using immune cells encoding chimeric receptors to treat or prevent cancer.
-
公开(公告)号:US20210079074A1
公开(公告)日:2021-03-18
申请号:US16943123
申请日:2020-07-30
Applicant: Alector LLC
Inventor: Jeonghoon SUN , Wei-Hsien HO , Muhammad A. ALHAWAGRI , Philip Ling KONG , Herve RHINN , Hua LONG , Karpagam SRINIVASAN , Ananya MITRA , Daniel P. BERMINGHAM , Klaus-Dieter HEGER , Santiago Viveros SALAZAR , Francesca CIGNARELLA , Ilaria TASSI , Tina SCHWABE , Angie Grace YEE , Arnon ROSENTHAL
IPC: C07K16/18
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal antibodies, humanized antibodies and antibody fragments, that specifically bind a MS4A4A polypeptide, e.g., a mammalian MS4A4A or human MS4A4A, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US20210040200A1
公开(公告)日:2021-02-11
申请号:US16965676
申请日:2019-01-31
Applicant: Alector LLC
Inventor: Philip KONG , Herve RHINN , Tina SCHWABE , Angie YEE , Ilaria TASSI , Muhammad Abbas ALHAWAGRI , Arnon ROSENTHAL
IPC: C07K16/28
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a MS4A4A polypeptide, e.g., a mammalian MS4A4A or human MS4A4A, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
公开(公告)号:US10676525B2
公开(公告)日:2020-06-09
申请号:US16054680
申请日:2018-08-03
Applicant: ALECTOR LLC
Inventor: Tina Schwabe , Eric Brown , Philip Kong , Ilaria Tassi , Seung-Joo Lee , Arnon Rosenthal , Robert Pejchal , Nels P. Nielson
Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a TREM2 protein, e.g., a mammalian TREM2 or human TREM2, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
-
-
-
-
-
-
-
-
-